Akari Therapeutics to Present Phase II Data from Bullous Pemphigoid Trial at European Academy of Dermatology and Venereology (EADV) Virtual Congress October 29
Stock Information for Akari Therapeutics Plc
Loading
Please wait while we load your information from QuoteMedia.